Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 One-year event-free survival in the current era for the intermediate-risk groups stratified by beta-blockers and defibrillator therapy shows survival in patients with both therapies simultaneously to be comparable to that after transplantation. p > 0.2 for peak exercise oxygen consumption (VO2) and p = 0.07 for heart failure survival score (HFSS). Open bars = no beta-blocker therapy; dotted bars = beta-blocker therapy; solid bars = beta-blocker and defibrillator therapy.
|
